19 July 2016
Brexit, if and when it happens, may have a substantial impact on the UK pharmaceutical industry. Although related issues will also have an impact upon many aspects of that industry, this note focuses on the key regulatory implications.
Industries: Life Sciences and Healthcare
Services: Administrative and Public Law, Government Relations and Policy Advocacy, Intellectual Property, Medical Device Law, Patents, Pharmaceutical and Biotechnology Regulatory Law